✦ LIBER ✦

Combination chemotherapy with vincristine, epirubicin and cyclophosphamide in small cell lung carcinoma

Book ID: 122079252
Publisher: Elsevier Science
Year: 1993
Tongue: English
Weight: 145 KB
Volume: 8
Category: Article
ISSN: 0169-5002
DOI: 10.1016/0169-5002(93)90575-I

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combination chemotherapy with vincristin

✍ Jassem, J.; Karnicka-Mlodkowska, H.; Drozd-Lula, M.; Strug, A.; Pilarska-Machowi 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 385 KB

Combination chemotherapy with cyclophosp

Combination chemotherapy with cyclophosphamide, epirubicin and etoposide in small cell lung cancer

✍ Jassem, J.; Karnicka-Mlodkowska, H.; Jassem, E.; Słupek, A.; Zych, J.; Wiatr, E. 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 619 KB

Combination chemotherapy with cyclophosp

Combination chemotherapy with cyclophosphamide, epirubicin and etoposide in small cell lung cancer

📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 138 KB

Cisplatin-VP16 alternating with cyclopho

Cisplatin-VP16 alternating with cyclophosphamide-epirubicin versus cyclophosphamide-epirubicin-vincristine in small cell lung cancer

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 173 KB

Chemotherapy combination with cyclophosp

Chemotherapy combination with cyclophosphamide (CTX) adriamycin (ADM), vincristine (VCR), and VP16-213 in small cell carcinoma of the lung (SCCL)

✍ J. M. Gracia; A. Jimenez 📂 Article 📅 1982 🏛 Springer 🌐 English ⚖ 178 KB

Twenty-four evaluable patients with small cell carcinoma of the lung were treated with an escalating chemotherapy regimen including Cyclophosphamide, Adriamycin, Vincristine and VP16-213. The initial doses were CTX 800 mg/m2 i.v. day 1; ADR 50 mg/m2 i.v. day 1; VCR 1.4 mg/m2 day 1 weekly; and VP16-2

Combination chemotherapy with cisplatin,

Combination chemotherapy with cisplatin, adriamycin, etoposide and cyclophosphamide (CAVE) in small cell lung carcinoma (SCLC)

📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 87 KB